BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 20413767)

  • 1. Squamous cell carcinoma of the palatine tonsils: FDG standardized uptake value ratio as a biomarker to differentiate tonsillar carcinoma from physiologic uptake.
    Davison JM; Ozonoff A; Imsande HM; Grillone GA; Subramaniam RM
    Radiology; 2010 May; 255(2):578-85. PubMed ID: 20413767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of 18F-FDG PET/CT as a predictive biomarker of outcome in patients with head-and-neck non-squamous cell carcinoma.
    Imsande HM; Davison JM; Truong MT; Devaiah AK; Mercier GA; Ozonoff AJ; Subramaniam RM
    AJR Am J Roentgenol; 2011 Oct; 197(4):976-80. PubMed ID: 21940588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal FDG distribution patterns in the head and neck: PET/CT evaluation.
    Nakamoto Y; Tatsumi M; Hammoud D; Cohade C; Osman MM; Wahl RL
    Radiology; 2005 Mar; 234(3):879-85. PubMed ID: 15734938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histogram Analysis of Apparent Diffusion Coefficients for Occult Tonsil Cancer in Patients with Cervical Nodal Metastasis from an Unknown Primary Site at Presentation.
    Choi YJ; Lee JH; Kim HO; Kim DY; Yoon RG; Cho SH; Koh MJ; Kim N; Kim SY; Baek JH
    Radiology; 2016 Jan; 278(1):146-55. PubMed ID: 26115452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palatine tonsil SUVmax on FDG PET-CT as a discriminator between benign and malignant tonsils in patients with and without head and neck squamous cell carcinoma of unknown primary.
    Pencharz D; Dunn J; Connor S; Siddiqui A; Sriskandan N; Thavaraj S; Jeannon JP; Oakley R; Lei M; Guerrero-Urbano T; Cook GJ; Szyszko TA
    Clin Radiol; 2019 Feb; 74(2):165.e17-165.e23. PubMed ID: 30454841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal FDG uptake in the adenoids and palatine tonsils in children on PET/MRI.
    Kumbhar SS; Qi J
    Pediatr Radiol; 2020 Jun; 50(7):958-965. PubMed ID: 32198664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of quantitative 18 F-fluorodeoxyglucose uptake measurement to identify occult tonsillar carcinoma in patients with cervical metastasis of unknown primary tumours: a retrospective case-control study.
    Lee HJ; Kim JS; Roh JL; Lee JH; Cho KJ; Park GC; Choi SH; Nam SY; Kim SY
    Clin Otolaryngol; 2013 Feb; 38(1):30-8. PubMed ID: 23167514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET/CT findings within the contralateral tonsil following unilateral tonsillectomy.
    Hirshoren N; Olayos E; Callahan J; Lau E
    Laryngoscope; 2016 Nov; 126(11):2480-2483. PubMed ID: 27114188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological FDG uptake in the palatine tonsils.
    Kawabe J; Okamura T; Shakudo M; Koyama K; Sakamoto H; Ohachi Y; Higashiyama S; Inoue Y; Yamada R; Ochi H
    Ann Nucl Med; 2001 Jun; 15(3):297-300. PubMed ID: 11545206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of 18F-FDG PET/CT in patients with squamous cell carcinoma of the tonsil: comparisons of volume-based metabolic parameters.
    Moon SH; Choi JY; Lee HJ; Son YI; Baek CH; Ahn YC; Park K; Lee KH; Kim BT
    Head Neck; 2013 Jan; 35(1):15-22. PubMed ID: 22307893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival.
    Kidd EA; Siegel BA; Dehdashti F; Grigsby PW
    Cancer; 2007 Oct; 110(8):1738-44. PubMed ID: 17786947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values.
    Abele JT; Fung CI
    Radiology; 2010 Mar; 254(3):917-24. PubMed ID: 20177102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of physiological uptake of 18F-fluorodeoxyglucose in palatine tonsils.
    Birkin E; Moore KS; Huang C; Christopher M; Rees JI; Jayaprakasam V; Fielding PA
    Medicine (Baltimore); 2018 Jun; 97(24):e11040. PubMed ID: 29901601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography: poor sensitivity for occult tonsillar cancer.
    Nabili V; Zaia B; Blackwell KE; Head CS; Grabski K; Sercarz JA
    Am J Otolaryngol; 2007; 28(3):153-7. PubMed ID: 17499129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of normal FDG uptake in palatine tonsil and its potential value for detecting occult head and neck cancers: a PET CT study.
    Wong WL; Gibson D; Sanghera B; Goodchild K; Saunders M
    Nucl Med Commun; 2007 Sep; 28(9):675-80. PubMed ID: 17667745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High 2-[18F]fluoro-2-deoxy-d-glucose (18FDG) uptake measured by positron emission tomography is associated with reduced overall survival in patients with oral squamous cell carcinoma.
    Hofele C; Freier K; Thiele OC; Haberkorn U; Buchmann I
    Oral Oncol; 2009 Nov; 45(11):963-7. PubMed ID: 19665923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography.
    Degirmenci B; Wilson D; Laymon CM; Becker C; Mason NS; Bencherif B; Agarwal A; Luketich J; Landreneau R; Avril N
    Nucl Med Commun; 2008 Jul; 29(7):614-22. PubMed ID: 18528183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma metastases to palatine tonsils obscured by physiological FDG uptake on PET/CT.
    Al-Ibraheem A; Souvatzoglou M; Buck A; Schwaiger M
    Clin Nucl Med; 2010 Feb; 35(2):101-2. PubMed ID: 20090457
    [No Abstract]   [Full Text] [Related]  

  • 19. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
    Kitagawa Y; Sano K; Nishizawa S; Nakamura M; Ogasawara T; Sadato N; Yonekura Y
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):63-71. PubMed ID: 12483411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of physiologic and abnormal glucose uptake in palatine tonsils: differential diagnostics with sequential dual-time-point 2-deoxy-2-[18F]FDG PET/CT.
    Pietrzak AK; Kazmierska J; Marszalek A; Cholewinski W
    Q J Nucl Med Mol Imaging; 2020 Sep; 64(3):299-306. PubMed ID: 30221906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.